U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07486960) titled 'Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)' on March 19.
Brief Summary: This study assesses the efficacy, safety, and tolerability of tulisokibart (MK-7240) in adult participants with active Psoriatic Arthritis.
Study Start Date: April 22
Study Type: INTERVENTIONAL
Condition:
Psoriatic Arthritis
Intervention:
DRUG: Tulisokibart
Subcutaneous administration
DRUG: Placebo
Subcutaneous administration
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Merck Sharp & Dohme LLC
Published by HT Digital Content Services with permission from Health Daily Digest....